Delivering Intentional Results
Our Approach
The Orbit SDS uses a flexible cannula designed to contour to the globe and access the back of the eye, targeting a subretinal location in the posterior segment.
The procedure enables precise infusate delivery to the subretinal space without removing the vitreous or creating a retinotomy.
Accessing the Subretinal Space
The Orbit SDS
The Orbit SDS was specifically designed and optimized for precise microinjection into the subretinal space.
Surgical Training
Gyroscope Therapeutics believes that continued surgeon and staff training are vital to the safe execution of any surgical procedure. Patients deserve to know that their healthcare professionals have taken key training steps to prepare them for their procedure.
Robust Surgical Training Program
Useful Resources
view ifu
View the Instructions for Use of Orbit SDS
About Gyroscope
We discover, develop and deliver innovative medicines to preserve people’s sight and fight the devastating impact of blindness around the world. Our ultimate goal for our patients is – Vision For Life. Visit the Gyroscope website to find out more about us, our people and our investigational gene therapies.
Contact Us
We'd love to hear from you. If you have an inquiry about our company, our investigational gene therapies, delivery systems or clinical trials, please contact us.
Follow Us
We discover, develop and deliver innovative medicines to preserve people’s sight and fight the devastating impact of blindness around the world. Our ultimate goal for our patients is – Vision For Life.
Orbit, Orbit SDS and the Orbit logos are trademarks of Gyroscope Therapeutics Limited.
© Gyroscope Therapeutics Limited, 2020.
All rights reserved
We are a global organization with teams based in:
- London, Stevenage – UK
- Philadelphia, San Francisco – USA